ArticleBMC medicine2022

Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.

Chengming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.